| Literature DB >> 26973172 |
Muhammad Nawaz1,2, Farah Fatima1,2, Irina Nazarenko3, Karin Ekström4,5, Iram Murtaza6, Mariam Anees6, Aneesa Sultan6, Luciano Neder1, Giovanni Camussi7, Hadi Valadi2, Jeremy A Squire1, Thomas Kislinger8.
Abstract
In recent years there has been tremendous interest in both the basic biology and applications of extracellular vesicles (EVs) in translational cancer research. This includes a better understanding of their biogenesis and mechanisms of selective cargo packaging, their precise roles in horizontal communication, and their application as non-invasive biomarkers. The rapid advances in next-generation omics technologies are the driving forces for these discoveries. In this review, the authors focus on recent results of EV research in ovarian cancer. A deeper understanding of ovarian cancer-derived EVs, the types of cargo molecules and their biological roles in cancer growth, metastases and drug resistance, could have significant impact on the discovery of novel biomarkers and innovative therapeutics. Insights into the role of EVs in immune regulation could lead to novel approaches built on EV-based immunotherapy.Entities:
Keywords: Extracellular vesicles; biomarkers; exosomes; glycoproteins; immunotherapy; matrix metalloproteinase; microRNAs; ovarian cancer
Mesh:
Substances:
Year: 2016 PMID: 26973172 DOI: 10.1586/14789450.2016.1165613
Source DB: PubMed Journal: Expert Rev Proteomics ISSN: 1478-9450 Impact factor: 3.940